Results for tag: "Ezlopitant"

Ezlopitant is a drug used to treat gastrointestinal disorders, such as nausea and vomiting. It is a neurokinin-1 (NK-1) receptor antagonist, which works by blocking the action of a chemical messenger in the brain that can cause nausea and vomiting. It is available in both oral and intravenous formulations. Ezlopitant is used to treat nausea and vomiting caused by chemotherapy, radiation therapy, and other conditions. It is also used to prevent nausea and vomiting in patients undergoing surgery. Ezlopitant is marketed by several pharmaceutical companies, including Merck, Pfizer, and Sanofi. It is available in both generic and brand-name formulations. Ezlopitant is approved for use in the United States, Europe, and other countries. It is also available in some countries as an over-the-counter medication. In the Ezlopitant market, Merck, Pfizer, and Sanofi are some of the leading companies. Other companies include AstraZeneca, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more